Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DLK1 (clone A1G0Z). We employs the AAV (SP6-YFP-c-Jun-KpnI) vector components and the SynExpress system of the Single base pair Deletion/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
DLK1
Clone
A1G0Z
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
YFP
Promoter
SP6
Effector Gene
c-Jun
Insertion Sites
KpnI
Gene Modification
Deletion
Modification Domain
Single base pair
Carrier Type
AAV
Transformation Accuracy
0.91
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.